Avro India (AVROIND)
Slow GrowerScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹130.05 |
| Market Cap | ₹115.79 Cr |
| P/E Ratio | 287.67 |
| ROCE | 0% |
| ROE | 5.27% |
| Dividend Yield | 0% |
| Profit Growth | 113.9% |
| Debt/Equity | 0.2 |
| Sales Growth | 39.3% |
| Promoter Holding | 54.07% |
| 52-Week Range | ₹7.62 — ₹159.9 |
| Sector | Consumer Durables |
| Book Value | ₹6.66 |
Strengths
- Low debt-to-equity of 0.27 provides financial stability
- Promoter holding at 54.07% aligns management with minority shareholders
- Book value per share of ₹22 offers some tangible asset backing
- ROE of 12.76% is respectable for a small-cap plastic products company
Concerns
- Extremely high valuation: P/E of 51.04 and P/B of 5.91 with zero growth
- Piotroski F-Score of 2/9 indicates weak financial health and operational efficiency
- ROCE reported at 0.00%, suggesting poor capital deployment
- No dividend yield and thin profit margin (4% in latest quarter) provide no income cushion
AI Analysis
Let's look at Avro India through a Graham-Buffett lens. The numbers tell a sobering story. At ₹130.05, the market caps this consumer plastics firm at ₹185 Cr. Yet trailing earnings support a P/E of 51. That is a rich price for a business with zero sales growth, zero profit growth, and zero dividend. Benjamin Graham would say you are paying a very high multiple for a stagnant enterprise. The latest quarter shows net profit of just ₹1 Cr on sales of ₹25 Cr — a thin 4% margin. Return on equity is 12.76%, which is decent, but it is not spectacular enough to justify a P/B of 5.91 against book value of ₹22. Piotroski F-Score of 2/9 is a flashing red light, suggesting deteriorating financial health. On the positive side, debt-to-equity is low at 0.27, and promoters hold 54.07%, which aligns their interests with mine. But the 52-week range — from ₹8 to ₹164.48 — tells me this stock has been driven by speculation, not by fundamentals. The ROCE is reported as 0.00%, which, if accurate, is deeply troubling. I need a margin of safety, and at 51 times earnings with no growth, there is none. This is not a business I would buy; it is a business I would wait to see drop to a rational price, or show real earnings acceleration. Until then, I pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer